Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

6P4P

Salmonella typhi PltB Homopentamer N29K Mutant

Summary for 6P4P
Entry DOI10.2210/pdb6p4p/pdb
DescriptorPutative pertussis-like toxin subunit (2 entities in total)
Functional Keywordspltb, toxin
Biological sourceSalmonella enterica subsp. enterica serovar Typhi str. CT18
Total number of polymer chains5
Total formula weight81602.39
Authors
Nguyen, T.,Milano, S.K.,Hillpot, E.C.,Yang, Y.A.,Song, J. (deposition date: 2019-05-28, release date: 2020-03-25, Last modification date: 2024-11-13)
Primary citationLee, S.,Yang, Y.A.,Milano, S.K.,Nguyen, T.,Ahn, C.,Sim, J.H.,Thompson, A.J.,Hillpot, E.C.,Yoo, G.,Paulson, J.C.,Song, J.
Salmonella Typhoid Toxin PltB Subunit and Its Non-typhoidal Salmonella Ortholog Confer Differential Host Adaptation and Virulence.
Cell Host Microbe, 27:937-949.e6, 2020
Cited by
PubMed Abstract: Typhoidal and non-typhoidal Salmonelleae (NTS) cause typhoid fever and gastroenteritis, respectively, in humans. Salmonella typhoid toxin contributes to typhoid disease progression and chronic infection, but little is known about the role of its NTS ortholog. We found that typhoid toxin and its NTS ortholog induce different clinical presentations. The PltB subunit of each toxin exhibits different glycan-binding preferences that correlate with glycan expression profiles of host cells targeted by each bacterium at the primary infection or intoxication sites. Through co-crystal structures of PltB subunits bound to specific glycan receptor moieties, we show that they induce markedly different glycan-binding preferences and virulence outcomes. Furthermore, immunization with the NTS S. Javiana or its toxin offers cross-reactive protection against lethal-dose typhoid toxin challenge. Cumulatively, these results offer insights into the evolution of host adaptations in Salmonella AB toxins, their cell and tissue tropisms, and the design for improved typhoid vaccines and therapeutics.
PubMed: 32396840
DOI: 10.1016/j.chom.2020.04.005
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2 Å)
Structure validation

227344

PDB entries from 2024-11-13

PDB statisticsPDBj update infoContact PDBjnumon